Navigation Links
InVitria Headlines Sponsorship of WilBio's Waterside Conference
Date:4/9/2009

Supplier of high performance cell culture media components will reveal significant advantages of its products at the 14th International Meeting of The Waterside Conference, April 20-22 in San Francisco.

Fort Collins, CO (PRWEB) April 9, 2009 -- InVitria's line of high performance cell culture media components used for mammalian cell culture will be showcased at the upcoming Williamsburg BioProcessing Foundation The Waterside Conference on April 20-22, 2009, in South San Francisco.

Regarded as one of the leading events addressing scale-up and production issues facing the bioprocessing industry, the 2009 Waterside Conference comes at an opportune time for InVitria to share its product advantages with commercial biomanufacturers.

InVitria's Cellastim (recombinant human serum albumin) and Lacromin (recombinant Lactoferrin) have been used by large-scale commercial manufacturers to significantly improve CHO cell growth and productivity. Cellastim also increases hybridoma cell growth and monoclonal antibody production.

InVitria's Director of Cell Culture, Dr. Steve Pettit, will present two posters at the conference revealing the optimization benefits of InVitria's Cellastim in CHO and hybridoma cell lines. "Recent research from our own work and that of customers shows substantial improvements in the speed of cell line development and seed-train expansion using InVitria's recombinant product," said Dr. Pettit. "This is especially important for our customers who want to eliminate animal-derived components and also expedite their product development process," he continued.

"We are glad to partner with WilBio as a sponsor for this industry-leading event," commented Scott Deeter, InVitria President and CEO. "At The Waterside Conference, we invite existing and new customers to visit our booth to learn how InVitria can help you optimize productivity, reduce product development time and achieve your regulatory objectives."

About InVitria
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture products and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research and diagnostics.

For more information about InVitria's products, please contact us by e-mail or phone.

E-mail: info(at)InVitria(dot)com
Phone: 1-800-916-8311

###

Read the full story at http://www.prweb.com/releases/WilBioWaterside/InVitria/prweb2314714.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. InVitria Announces Launch of Recombinant Albumin for Diagnostics
2. InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
3. InVitria's Cellastim Delivers Superior Results in CHO Cell Culture
4. InVitria to Launch "BE FREE" Promotion at TERMIS '08 in San Diego
5. InVitria to Showcase its Innovative Cell Culture Components at American Society of Cell Biology Annual Meeting
6. InVitria to Present at WilBio's International Cell Engineering Meeting
7. Oprah Show Expert and RealAge Cofounder Headlines ePharma Talk
8. Good News in Africa: Beyond the headlines
9. Fitness Model / Entrepreneur Targets Childhood Obesity and Makes Headlines Nationwide With New Franchise Offering
10. NHS Choices Launches Medical News Guide to What Lies Behind the Headlines
11. THE Aesthetic Show Attracts Record Sponsorship
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Splashtop Inc. ... Pro . This new addition to the Mirroring360 product family combines device screen ... , Mirroring360 Pro enables educators, business professionals and individuals to stream or mirror ...
(Date:4/25/2017)... ... 2017 , ... As President Trump challenges the status quo ... administration could impact the employee benefits industry. James Slotnick, AVP, Government Relations, for ... make it through Congress. His discussion will focus on the current state of ...
(Date:4/25/2017)... ... 25, 2017 , ... Patients who would like to straighten ... fraction of the time as traditional braces – Wilckodontics®. Dr. Victoria Chen, an ... this revolutionary treatment with or without a referral. , Wilckodontics is also ...
(Date:4/25/2017)... ... ... Buyers and sellers in the thriving multi-billion dollar cannabis marketplace – from medical ... heartened by the industry’s current surge. But another thing that unifies them is a ... last they can simply, safely and effectively end their aroma anguish thanks to a ...
(Date:4/25/2017)... ... April 25, 2017 , ... There is no better place in South ... special report in the May issue of Consumer Reports focused on heart health. ... results achieved during and after coronary bypass and aortic valve replacement procedures. , ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Research and Markets has announced the addition ... Addressing Production Complexities Through Risk Management and Quality by ... ... Market Prospects: Overcoming Production Complexities Through Risk Management and ... current trends in the global biosimilars market, with a ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ABBV), ... percent (n=145/146) of chronic hepatitis C virus (HCV) ... or 6 and compensated cirrhosis (Child-Pugh A) achieved ... 12 ) with its investigational, pan-genotypic regimen of ... were seen following 12 weeks of G/P treatment ...
(Date:4/19/2017)... CRH) (NYSE MKT: CRHM) (the "Company"), announces that it will participate ... the Sheraton Hotel in Toronto, Ontario . ... is scheduled to present on Tuesday, May 2 at 10:00 am. ... the Board, Tony Holler will also attend the event. ... For more details about the ...
Breaking Medicine Technology: